Clinical Trials · NCT06686134

Comprehensive Clinical Evaluation Study of GLP-1RA

RecruitingN/ASemaglutide (Investigational)Liraglutide (Investigational)
Phase
N/A
Recruitment status
Recruiting
Sponsor
LI YAN
Enrollment
492
Start date
Jul 2024
Locations
1 site, China
Primary endpoint
HbA1c compliance rate
View Semaglutide compound reference